Financhill
Buy
61

AGX Quote, Financials, Valuation and Earnings

Last price:
$139.47
Seasonality move :
6.78%
Day range:
$133.00 - $142.79
52-week range:
$43.44 - $165.33
Dividend yield:
0.92%
P/E ratio:
29.15x
P/S ratio:
2.38x
P/B ratio:
5.75x
Volume:
473.8K
Avg. volume:
305.5K
1-year change:
199.96%
Market cap:
$1.9B
Revenue:
$573.3M
EPS (TTM):
$4.78
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Revenue $239M $392.2M $509.4M $455M $573.3M
Revenue Growth (YoY) -50.43% 64.11% 29.87% -10.67% 26%
 
Cost of Revenues $245.8M $330.1M $409.6M $368.7M $492.5M
Gross Profit -$6.8M $62.1M $99.7M $86.4M $80.8M
Gross Profit Margin -2.85% 15.83% 19.58% 18.98% 14.1%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $44.1M $39M $47.3M $44.7M $44.4M
Other Inc / (Exp) $3.2M $1.9M -$5.3M $4.3M $12.5M
Operating Expenses $44.1M $39M $47.3M $44.7M $44.4M
Operating Income -$50.9M $23M $52.4M $41.7M $36.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$47.8M $24.9M $47.1M $46M $48.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$7.1M $1.1M $11.4M $11.3M $16.6M
Net Income to Company -$40.7M $23.8M $35.7M $34.7M $32.4M
 
Minority Interest in Earnings -$2M $40K $2.5M -$1.6M --
Net Income to Common Excl Extra Items -$42.7M $23.9M $38.2M $33.1M $32.4M
 
Basic EPS (Cont. Ops) -$2.73 $1.52 $2.43 $2.35 $2.42
Diluted EPS (Cont. Ops) -$2.73 $1.51 $2.40 $2.33 $2.39
Weighted Average Basic Share $15.6M $15.7M $15.7M $14.1M $13.4M
Weighted Average Diluted Share $15.6M $15.8M $15.9M $14.2M $13.5M
 
EBITDA -$46.3M $27.6M $56.6M $45.4M $38.9M
EBIT -$50.9M $23M $52.4M $41.7M $36.5M
 
Revenue (Reported) $239M $392.2M $509.4M $455M $573.3M
Operating Income (Reported) -$50.9M $23M $52.4M $41.7M $36.5M
Operating Income (Adjusted) -$50.9M $23M $52.4M $41.7M $36.5M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $127.3M $124.5M $117.9M $163.8M $257M
Revenue Growth (YoY) 118.01% -2.26% -5.28% 38.92% 56.95%
 
Cost of Revenues $107M $98.3M $95.7M $144.5M $212.7M
Gross Profit $20.3M $26.1M $22.2M $19.2M $44.3M
Gross Profit Margin 15.98% 21% 18.84% 11.75% 17.25%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $9.4M $11.6M $12.7M $11.4M $14M
Other Inc / (Exp) $175K $1.1M $768K $3.7M $6.6M
Operating Expenses $9.4M $11.6M $12.7M $11.4M $14M
Operating Income $10.9M $14.5M $9.5M $7.9M $30.3M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $11.1M $15.7M $10.3M $11.6M $37M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.7M $3.3M $2.6M $6.1M $9M
Net Income to Company $9.5M $12.4M $7.8M $5.5M $28M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $9.5M $12.4M $7.8M $5.5M $28M
 
Basic EPS (Cont. Ops) $0.60 $0.79 $0.56 $0.41 $2.07
Diluted EPS (Cont. Ops) $0.60 $0.78 $0.56 $0.40 $2.00
Weighted Average Basic Share $15.7M $15.8M $13.8M $13.3M $13.5M
Weighted Average Diluted Share $15.8M $16M $13.8M $13.6M $14M
 
EBITDA $12.1M $15.6M $10.5M $8.4M $30.9M
EBIT $10.9M $14.5M $9.5M $7.9M $30.3M
 
Revenue (Reported) $127.3M $124.5M $117.9M $163.8M $257M
Operating Income (Reported) $10.9M $14.5M $9.5M $7.9M $30.3M
Operating Income (Adjusted) $10.9M $14.5M $9.5M $7.9M $30.3M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $343M $501M $461.8M $527.6M $806.3M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $297.7M $401.4M $373.3M $450.3M $689.3M
Gross Profit $45.2M $99.6M $88.6M $77.2M $117M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $41.2M $42M $49.7M $42.9M $49.8M
Other Inc / (Exp) -$506K $1.7M -$5.1M $9.7M $22.3M
Operating Expenses $41.2M $42M $49.7M $42.9M $49.8M
Operating Income $4M $57.6M $38.8M $34.3M $67.3M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $3.5M $59.3M $33.8M $44M $89.5M
Earnings of Discontinued Ops. $3.1M -- -- -- --
Income Tax Expense -- $13.7M $14.6M $8.4M $23.4M
Net Income to Company $7M $45.6M $19.1M $35.6M $66.1M
 
Minority Interest in Earnings $70K -- -- -- --
Net Income to Common Excl Extra Items $7.1M $45.6M $21.7M $34M $66.1M
 
Basic EPS (Cont. Ops) $0.45 $2.90 $1.50 $2.53 $4.92
Diluted EPS (Cont. Ops) $0.45 $2.86 $1.50 $2.50 $4.78
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $8.7M $61.9M $42.7M $36.9M $69.5M
EBIT $4M $57.6M $38.8M $34.3M $67.3M
 
Revenue (Reported) $343M $501M $461.8M $527.6M $806.3M
Operating Income (Reported) $4M $57.6M $38.8M $34.3M $67.3M
Operating Income (Adjusted) $4M $57.6M $38.8M $34.3M $67.3M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $275M $383.8M $336.3M $408.8M $641.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $235M $306.3M $269.9M $351.6M $548.3M
Gross Profit $40M $77.5M $66.3M $57.2M $93.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $28.8M $31.8M $34.2M $32.5M $37.8M
Other Inc / (Exp) $1.7M $1.6M $1.9M $7.2M $17M
Operating Expenses $28.8M $31.8M $34.2M $32.5M $37.8M
Operating Income $11.2M $45.7M $32.1M $24.7M $55.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $12.9M $47.3M $34M $32M $72.6M
Earnings of Discontinued Ops. $3.1M -- -- -- --
Income Tax Expense $1.7M $11.2M $14.5M $11.6M $18.5M
Net Income to Company $14.3M $36M $19.5M $20.3M $54.1M
 
Minority Interest in Earnings $40K -- -- -- --
Net Income to Common Excl Extra Items $14.3M $36M $19.5M $20.3M $54.1M
 
Basic EPS (Cont. Ops) $0.91 $2.29 $1.36 $1.52 $4.02
Diluted EPS (Cont. Ops) $0.91 $2.26 $1.36 $1.50 $3.89
Weighted Average Basic Share $47M $47.3M $42.8M $40.1M $40.2M
Weighted Average Diluted Share $47.3M $47.9M $43.1M $40.6M $41.5M
 
EBITDA $14.6M $48.9M $35M $26.6M $57.2M
EBIT $11.2M $45.7M $32.1M $24.7M $55.5M
 
Revenue (Reported) $275M $383.8M $336.3M $408.8M $641.7M
Operating Income (Reported) $11.2M $45.7M $32.1M $24.7M $55.5M
Operating Income (Adjusted) $11.2M $45.7M $32.1M $24.7M $55.5M
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Cash and Equivalents $167.4M $366.7M $350.5M $173.9M $197M
Short Term Investments $160.5M $90.1M $90M $151.5M $215.4M
Accounts Receivable, Net $37.2M $28.7M $27M $50.1M $47.3M
Inventory -- -- $738K $11.9M $10M
Prepaid Expenses -- -- $32.4M $4.5M $6M
Other Current Assets $23.3M $34.1M $1.8M $6.6M $5M
Total Current Assets $421.8M $546.2M $507.3M $438.7M $547.2M
 
Property Plant And Equipment $24.9M $24.1M $14.5M $16.5M $18.5M
Long-Term Investments -- -- -- -- --
Goodwill $27.9M $27.9M $28M $28M $28M
Other Intangibles $5M $4.1M $3.3M $2.6M $2.2M
Other Long-Term Assets -- -- -- -- --
Total Assets $487.5M $602.6M $553.6M $489.5M $598.2M
 
Accounts Payable $35.4M $53.3M $41.8M $56.4M $39.5M
Accrued Expenses $35.9M $50.8M $33.3M $30M $57.8M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- $1.4M $1.6M $2.7M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $144M $276.1M $223M $202.5M $302.3M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $146.5M $280.2M $228M $208.6M $307.3M
 
Common Stock $2.3M $2.4M $2.4M $2.4M $2.4M
Other Common Equity Adj -$1.1M -$1.1M -$2.5M -$2.9M -$3.6M
Common Equity $339.2M $320.7M $326.4M $280.9M $290.9M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.8M $1.7M -$797K -- --
Total Equity $341M $322.4M $325.6M $280.9M $290.9M
 
Total Liabilities and Equity $487.5M $602.6M $553.6M $489.5M $598.2M
Cash and Short Terms $327.9M $456.7M $440.5M $325.5M $412.4M
Total Debt -- -- -- -- --
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Cash and Equivalents $353.2M $391.6M $136.1M $185.6M $175.3M
Short Term Investments $90M $90M $150.6M $211.9M $330.9M
Accounts Receivable, Net $30.6M $35.8M $37.9M $49.9M $131.7M
Inventory -- -- -- $12.4M $3.4M
Prepaid Expenses -- -- -- $6.1M $6.6M
Other Current Assets $37.8M $32.5M $28.9M $6.1M $5.7M
Total Current Assets $538.8M $559.7M $365M $514.1M $717.1M
 
Property Plant And Equipment $24.4M $22.1M $15.2M $16.1M $20.5M
Long-Term Investments -- -- -- -- --
Goodwill $27.9M $27.9M $28M $28M $28M
Other Intangibles $4.3M $3.4M $2.7M $2.3M $1.9M
Other Long-Term Assets -- -- -- -- --
Total Assets $595.5M $613.2M $410.9M $563.7M $768.9M
 
Accounts Payable $48.8M $40M $45.3M $34.5M $87.1M
Accrued Expenses $51.7M $42.7M $40.2M $63.8M $52.6M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- $1.4M $2.6M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $261M $259M $134.5M $273.9M $436.2M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $264.8M $263.4M $139.2M $278.8M $440.2M
 
Common Stock $2.4M $2.4M $2.4M $2.4M $2.4M
Other Common Equity Adj -$1.8M -$1.8M -$5.1M -$4.7M -$5.7M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.7M $1.7M -$797K -- --
Total Equity $330.7M $349.8M $271.7M $284.8M $328.7M
 
Total Liabilities and Equity $595.5M $613.2M $410.9M $563.7M $768.9M
Cash and Short Terms $443.2M $481.6M $286.6M $397.5M $506.3M
Total Debt -- -- -- -- --
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Net Income to Stockholders -$40.7M $23.8M $35.7M $34.7M $32.4M
Depreciation & Amoritzation $4.6M $4.6M $4.2M $3.7M $2.4M
Stock-Based Compensation $2.1M $2.9M $3.5M $4M $4.5M
Change in Accounts Receivable $23.9M $15.2M $21.3M -$43.1M -$20.6M
Change in Inventories -- -- -- -- --
Cash From Operations $53.6M $176M $28.4M -$30.1M $116.9M
 
Capital Expenditures $7.1M $1.7M $1.4M $3.4M $2.8M
Cash Acquisitions -- -$1.3M -$5.6M -- -$5.1M
Cash From Investing -$36.1M $67M -$7M -$63.1M -$67.6M
 
Dividends Paid (Ex Special Dividend) -$15.6M -$47M -$15.7M -$14M -$14.7M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$20.4M -$68.2M -$12.5M
Other Financing Activities -- -- -- -$677K --
Cash From Financing -$14M -$45.4M -$34.6M -$82.8M -$26.1M
 
Beginning Cash (CF) $164.3M $167.4M $366.7M $350.5M $173.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $3.5M $197.6M -$13.2M -$176M $23.2M
Ending Cash (CF) $167.4M $366.7M $350.5M $173.9M $197M
 
Levered Free Cash Flow $46.5M $174.3M $27M -$33.4M $114.1M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders $9.5M $12.4M $7.8M $5.5M $28M
Depreciation & Amoritzation $1.2M $1M $952K $587K $531K
Stock-Based Compensation $785K $912K $1.1M $1.2M $1.2M
Change in Accounts Receivable -$1.6M $22.8M -$15.9M -$10.1M -$35.1M
Change in Inventories -- -- -- -- --
Cash From Operations $39.7M -$5.5M -$16.2M $57.7M $31.8M
 
Capital Expenditures $279K $112K $1.9M $1.1M $2.5M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$65.3M -$50.1M $23.3M -$70.3M -$82.3M
 
Dividends Paid (Ex Special Dividend) -$3.9M -$3.9M -$3.4M -$4M -$5.2M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$10.1M -$1.7M -$459K
Other Financing Activities -- -- -- $1.1M -$3.7M
Cash From Financing -$3.4M -$3.6M -$13.5M -$5.6M -$6.9M
 
Beginning Cash (CF) $382.4M $451.4M $143.3M $204.8M $232.7M
Foreign Exchange Rate Adjustment -$190K -$681K -$893K -$1M $101K
Additions / Reductions -$29M -$59.2M -$6.4M -$18.2M -$57.4M
Ending Cash (CF) $353.2M $391.6M $136.1M $185.6M $175.3M
 
Levered Free Cash Flow $39.4M -$5.6M -$18.2M $56.6M $29.2M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders $7M $45.6M $19.1M $35.6M $66.1M
Depreciation & Amoritzation $4.7M $4.4M $3.9M $2.6M $2.3M
Stock-Based Compensation $2.8M $3.3M $4M $4.3M $4.4M
Change in Accounts Receivable $27.4M $12.1M -$6M -$26M -$101.7M
Change in Inventories -- -- -- -- --
Cash From Operations $180.2M $75.2M -$86.3M $135.2M $147.6M
 
Capital Expenditures $2.2M $1.4M $2.9M $2.9M $5.8M
Cash Acquisitions -- -$5.4M -$1.5M -- -$8.4M
Cash From Investing -$50.2M -$6.8M -$64.2M -$62.7M -$132.6M
 
Dividends Paid (Ex Special Dividend) -$31.3M -$31.5M -$14.4M -$14.1M -$17.3M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$83.6M -$13.5M -$4.6M
Other Financing Activities -- -- -- -- --
Cash From Financing -$30M -$29.7M -$97.9M -$27.1M -$25.6M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $100M $38.7M -$248.4M $45.4M -$10.6M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $178.1M $73.7M -$89.2M $132.3M $141.7M
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders $14.3M $36M $19.5M $20.3M $54.1M
Depreciation & Amoritzation $3.5M $3.2M $2.9M $1.8M $1.7M
Stock-Based Compensation $2.2M $2.5M $3.1M $3.4M $3.4M
Change in Accounts Receivable $12.7M $9.6M -$17.6M -$445K -$81.5M
Change in Inventories -- -- -- -- --
Cash From Operations $142.6M $41.7M -$73M $92.3M $123M
 
Capital Expenditures $1.4M $1.1M $2.6M $2.1M $5.2M
Cash Acquisitions -- -$4.1M -- -- -$3.3M
Cash From Investing $68.6M -$5.2M -$62.3M -$61.9M -$126.8M
 
Dividends Paid (Ex Special Dividend) -$27.4M -$11.8M -$10.6M -$10.7M -$13.3M
Special Dividend Paid $1M -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$63.3M -$8.5M -$646K
Other Financing Activities -- -- -- $1.1M -$3.7M
Cash From Financing -$26.2M -$10.4M -$73.8M -$18M -$17.6M
 
Beginning Cash (CF) $812.7M $1.2B $686.1M $574.7M $637.5M
Foreign Exchange Rate Adjustment $877K -$1.2M -$5.3M -$710K -$185K
Additions / Reductions $185M $26.1M -$209.1M $12.3M -$21.5M
Ending Cash (CF) $998.6M $1.2B $471.7M $586.3M $615.8M
 
Levered Free Cash Flow $141.1M $40.6M -$75.6M $90.1M $117.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock